280 related articles for article (PubMed ID: 29241918)
1. Human amniotic fluid stem cells have better potential in early second trimester of pregnancy and can be reprogramed to iPS.
Shaw SWS; Cheng PJ; Chang YL; Chao AS; Wang TH; Chang SD; Hsieh TT; Chang KH
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):770-774. PubMed ID: 29241918
[TBL] [Abstract][Full Text] [Related]
2. Isolation of c-Kit+ human amniotic fluid stem cells from second trimester.
Pozzobon M; Piccoli M; Schiavo AA; Atala A; De Coppi P
Methods Mol Biol; 2013; 1035():191-8. PubMed ID: 23959992
[TBL] [Abstract][Full Text] [Related]
3. Isolation and differentiation of human mesenchymal stem cells obtained from second trimester amniotic fluid; experiments at Chang Gung Memorial Hospital.
Peng HH; Wang TH; Chao AS; Chang SD
Chang Gung Med J; 2007; 30(5):402-7. PubMed ID: 18062170
[TBL] [Abstract][Full Text] [Related]
4. [Isolation and biological characterization of human amniotic fluid-derived stem cells].
Guan T; Chen XL; Wei YJ; Lai Y; Xie LY; Liu ZY; Zhang XM; Liu HQ; Zhang JJ; Xie XY; Liu SL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):15-8. PubMed ID: 22455123
[TBL] [Abstract][Full Text] [Related]
5. Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette.
Fan Y; Luo Y; Chen X; Li Q; Sun X
J Reprod Dev; 2012; 58(4):404-9. PubMed ID: 22498813
[TBL] [Abstract][Full Text] [Related]
6. Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational age.
Di Trapani M; Bassi G; Fontana E; Giacomello L; Pozzobon M; Guillot PV; De Coppi P; Krampera M
Stem Cells Dev; 2015 Jan; 24(1):132-43. PubMed ID: 25072397
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of mesenchymal stem cells from human amniotic fluid to vascular endothelial cells.
Tancharoen W; Aungsuchawan S; Pothacharoen P; Markmee R; Narakornsak S; Kieodee J; Boonma N; Tasuya W
Acta Histochem; 2017 Mar; 119(2):113-121. PubMed ID: 28017358
[TBL] [Abstract][Full Text] [Related]
8. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol.
Tsai MS; Lee JL; Chang YJ; Hwang SM
Hum Reprod; 2004 Jun; 19(6):1450-6. PubMed ID: 15105397
[TBL] [Abstract][Full Text] [Related]
9. Highly potent stem cells from full-term amniotic fluid: A realistic perspective.
Hamid AA; Joharry MK; Mun-Fun H; Hamzah SN; Rejali Z; Yazid MN; Thilakavathy K; Nordin N
Reprod Biol; 2017 Mar; 17(1):9-18. PubMed ID: 28262444
[TBL] [Abstract][Full Text] [Related]
10. Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuli.
Zhang P; Baxter J; Vinod K; Tulenko TN; Di Muzio PJ
Stem Cells Dev; 2009 Nov; 18(9):1299-308. PubMed ID: 19508152
[TBL] [Abstract][Full Text] [Related]
11. Expression of a Hoechst 33342 efflux phenomenon and common characteristics of pluripotent stem cells in a side population of amniotic fluid cells.
Tsai YL; Chang YJ; Chou CY; Cheong ML; Tsai MS
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):139-44. PubMed ID: 20708517
[TBL] [Abstract][Full Text] [Related]
12. Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases.
Antonucci I; Provenzano M; Rodrigues M; Pantalone A; Salini V; Ballerini P; Borlongan CV; Stuppia L
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110774
[TBL] [Abstract][Full Text] [Related]
13. Comparative Transcriptome Analysis of Cell-Free Fetal RNA from Amniotic Fluid and RNA from Amniocytes in Uncomplicated Pregnancies.
Kang JH; Park HJ; Jung YW; Shim SH; Sung SR; Park JE; Cha DH; Ahn EH
PLoS One; 2015; 10(7):e0132955. PubMed ID: 26181329
[TBL] [Abstract][Full Text] [Related]
14. Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia.
Schiavo AA; Franzin C; Albiero M; Piccoli M; Spiro G; Bertin E; Urbani L; Visentin S; Cosmi E; Fadini GP; De Coppi P; Pozzobon M
Stem Cell Res Ther; 2015 Oct; 6():209. PubMed ID: 26519360
[TBL] [Abstract][Full Text] [Related]
15. Second trimester amniotic fluid annexin A5 levels and subsequent development of intrauterine growth restriction.
Dundar O; Yoruk P; Tutuncu L; Muhcu M; Ipcioglu O; Ergur AR; Mungen E
Prenat Diagn; 2008 Oct; 28(10):887-91. PubMed ID: 18792921
[TBL] [Abstract][Full Text] [Related]
16. [Isolation of human pluripotent mesenchymal stem cells from second-trimester amniotic fluid using two kinds of culture protocol and their differentiation into neuron-like cells].
Feng JX; La XL; Ma Y; Bi XJ; Wen H
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Dec; 21(12):729-33. PubMed ID: 20042139
[TBL] [Abstract][Full Text] [Related]
17. Isolation of human mesenchymal stem cells from third-trimester amniotic fluid.
You Q; Cai L; Zheng J; Tong X; Zhang D; Zhang Y
Int J Gynaecol Obstet; 2008 Nov; 103(2):149-52. PubMed ID: 18760782
[TBL] [Abstract][Full Text] [Related]
18. Why cell culture is successful after early amniocentesis.
Byrne D; Azar G; Nicolaides K
Fetal Diagn Ther; 1991; 6(1-2):84-6. PubMed ID: 1768350
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the concentrations of interleukin 15 in amniotic fluid in the second and the third trimesters of pregnancy.
Klimkiewicz-Blok D; Florjański J; Zalewski J; Blok R
Adv Clin Exp Med; 2012; 21(1):75-9. PubMed ID: 23214303
[TBL] [Abstract][Full Text] [Related]
20. Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications.
Moraghebi R; Kirkeby A; Chaves P; Rönn RE; Sitnicka E; Parmar M; Larsson M; Herbst A; Woods NB
Stem Cell Res Ther; 2017 Aug; 8(1):190. PubMed ID: 28841906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
